Navigation Links
New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
Date:4/11/2012

so, a six-year (2003-2008) historic analysis is provided for additional perspective.

An Executive Summary of this research and a free sample of the full report are available at http://www.giiresearch.com/report/go236736-chiral-technology.html

Laboratory Chemical Reagents: A Global Strategic Business Report

GIA projects the global market for laboratory chemical reagents to reach $18 billion by the year 2017, driven by technological advancements that are enhancing scientific community's ability to identify and produce important human therapeutic agents. Emerging applications areas and expanding commercial applications are expected to further fuel growth in the market.

The new laboratory chemical reagents market research from GIA provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) across geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia Pacific, Latin America and Rest of World. Key product segments analyzed include Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression Vectors Cloning & Sequencing, Gene Synthesis, Extraction Kits, PCR Reagents, Enzymes, and Others), Biochemistry (IVD), Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing (Pesticide Residues and Others).

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/go236849-laboratory-chemical-reagents.html

Electrophoresis Equipment and S
'/>"/>

SOURCE Global Information, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
3. Biotech firm spun off from Childrens Hospital raises $7 million to advance vascular treatment
4. New project could herald cheaper and more efficient biotechnology
5. Sustainable land use strategies to support bioenergy described in Industrial Biotechnology journal
6. 2012 Biotechnology and Pharmaceuticals: Forthcoming Conferences and Exhibitions
7. BGI enters agreement with National Center for Soybean Biotechnology to re-sequence 1,008 soybean lines
8. Exploiting Trichoderma: From food security to biotechnology
9. Andromeda Biotech: A drug for type 1 diabetes
10. Biotech start-up brings DNA-sequencing to the medical market
11. FDA grants cardiotrophin-1 Orphan Drug status for acute liver failure treatment to Digna Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... it has joined The Smart Card Alliance and the ... Card Alliance and the Smart Card Alliance Latin America ... to industry peers and thought leaders promoting adoption of ...
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... which become accustomed to ignoring genetically engineered chemical alarms ... become easy prey for ladybugs. That,s good news for ... for Plant Research and Cornell University. ( Proceedings of ... The study, "Alarm pheromone habituation in Myzus persicae ...
... Research is continually emerging on the impacts ... ecosystems and communities. Ecological scientists will discuss widespread ... plants in the wild to the implications of ... exploring society,s reactive mode toward environmental disasters in ...
... cell division, microtubules emanating from each of the spindle ... Scientists at the European Molecular Biology Laboratory (EMBL) in ... the extent of this overlap. In a study published ... reconstruct such anti-parallel microtubule overlaps in vitro, and identify ...
Cached Biology News:Apathetic aphids with attitude become easier prey for ladybugs 2Scientists find new evidence of genetically modified plants in the wild 2Scientists find new evidence of genetically modified plants in the wild 3Scientists find new evidence of genetically modified plants in the wild 4Constant overlap 2
(Date:8/27/2015)... PARK, N.C. , Aug. 27, 2015 /PRNewswire/ ... the decision by FedEx, UPS and The US ... certain biological specimens classified as ,select agents, by ... long history of handling these sensitive shipments. ... of global transportation regulations, trained and certified personnel ...
(Date:8/26/2015)... 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended June 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... to our Oral Amp B program, rapidly advancing ... Andrew Rae , President & CEO of ...
(Date:8/26/2015)... MIAMI , Aug. 26, 2015  The ... at the University of Miami Miller School of ... its clinical trial to test for the first ... was successfully completed.  This FDA approved Phase I/II ... islet transplantation and is an important first step ...
(Date:8/26/2015)... 26, 2015 Israel Proves Its Place in ... st place  Wayerz comes in 5 th ... by venture capital fund JVP, with Chinese consulting firm ... China , Israel , ... Impressive achievement for the Israeli representatives in the final round ...
Breaking Biology Technology:Marken Ensures Safe Transportation Of Select Agents And Toxins 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
... havoc on bacteria as well as humans and, just like ... Professor John van der Oost, at the Society for General ... system" could be used to keep industrial microbes at peak ... Wageningen University in the Netherlands have spent the last three ...
... ... minutes post-dose using electronic patient diary data , ... PITTSBURGH, PA (Vocus) March 31, 2010 -- invivodata, ... global clinical research, today announced that its DiaryPRO® field-based ePRO solution captured ...
... system senses and tracks down infection in the body by ... cells manipulate their movement in response to external signals could ... but also how cancer cells spread through the body and ... Society for General Microbiology,s spring meeting in Edinburgh, Dr Holger ...
Cached Biology Technology:invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial 2invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial 3How immune cells 'sniff out' bacteria 2